Piper Sandler analyst James Fish lowered the firm’s price target on Nutanix (NTNX) to $72 from $88 and keeps an Overweight rating on the shares. The firm notes shares were down about 15% after hours following the fade seen over the last few weeks as for the first time in more than 5 years Nutanix missed expectations, which given the issues being seen and extrapolated forward, resulted in a 3% cut to FY26 guide.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTNX:
- Nutanix: Strong Fundamentals and Financial Resilience Justify Buy Rating Despite Revenue Timing Challenges
- Nutanix price target lowered to $65 from $95 at KeyBanc
- Nutanix price target lowered to $57 from $71 at Wells Fargo
- Nutanix price target lowered to $75 from $93 at BofA
- Nutanix’s Future Potential and Revenue Timing: A Buy Rating Despite Short-term Adjustments